Journal of Pharmaceutical Investigation

, Volume 49, Issue 1, pp 1–8 | Cite as

Enhanced photodyamic therapy via photosensitizer-loaded nanoparticles for cancer treatment

  • Geunwoo Jeon
  • Young Tag KoEmail author


Cancer is one of the most challenging human disease to cure, and has high rate to death. The current major cancer treatments include surgery, chemotherapy and radiation therapy. However, these treatments have a lot of obstacles that included low efficacy, mortality and severe aftereffects. Photodynamic therapy is developing cancer therapy that photosensitizer (PS) transfers energy from light to molecular oxygen damaged to generate reactive oxygen species (ROS). These reactions occur in the immediate locale of the light-absorbing PS. Almost of PSs have obstacle to adjust in human body system. Nanoparticle systems (NS) were used to overcome problems like drug solubility, delivery and low efficacy. Nanoparticles loaded anticancer drug, small molecule drug, biomedicine and PSs. In this review, we summarize the studies that have confirmed the nanoparticle systems loading PSs which are Phthalocyanine 4, Photofrin®, Temoporfin, Levulan® and Foscan® cancer therapy and discuss the future direction for the this novel therapy.


Nanoparticles Photodynamic therapy Photosensitizer Drug delivery Tumor 



This research was supported by the Basic Science Research Program (NRF-2017R1A2B4002743) and the Pioneer Research Center Program (NRF 2014M3C1A3054153) of the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology.

Compliance with ethical standards

Conflict of interest

All authors (G. Jeon, Y. T. KO) declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human and animal subjects performed by any of the authors.


  1. Abd-Elgaliel WR, Cruz-Monserrate Z, Wang H et al (2013) Pancreatic cancer-associated Cathepsin E as a drug activator. J Control Release 167(3):221–227. CrossRefGoogle Scholar
  2. Akimoto J (2016) Photodynamic therapy for malignant brain tumors. Neurol Med Chir (Tokyo) 56(4):151–157. CrossRefGoogle Scholar
  3. Bolzinger M-A, Briançon S, Pelletier J et al (2012) Penetration of drugs through skin, a complex rate-controlling membrane. Curr Opin Colloid Interface Sci 17(3):156–165. CrossRefGoogle Scholar
  4. Brezaniova I, Hruby M, Kralova J et al (2016) Temoporfin-loaded 1-tetradecanol-based thermoresponsive solid lipid nanoparticles for photodynamic therapy. J Control Release 241:34–44. CrossRefGoogle Scholar
  5. Calixto GM, Bernegossi J, de Freitas LM et al (2016) Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review. Molecules 21(3):342. CrossRefGoogle Scholar
  6. Chan MH, Pan YT, Lee IJ et al (2017) Minimizing the heat effect of photodynamic therapy based on inorganic nanocomposites mediated by 808 nm near-infrared light. Small 13(21).
  7. Choi JH, Lee YJ, Kim D (2016) Image-guided nanomedicine for cancer. J Pharm Invest 47(1):51–64. CrossRefGoogle Scholar
  8. Delmas T, Piraux H, Couffin AC, Texier I, Vinet F, Poulin P, Cates ME, Bibette J (2011) How to prepare and stabilize very small nanoemulsions. Int J Pharm 27(5):1683–1692Google Scholar
  9. Di Corato R, Béalle G, Kolosnjaj-Tabi J, Espinosa A, Cle´ment O, Silva AK, Me´nager C, Wilhelm C (2014) Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes. Am Chem Soc 9:2904–2916Google Scholar
  10. Dixit S, Novak T, Miller K et al (2015a) Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors. Nanoscale 7(5):1782–1790. CrossRefGoogle Scholar
  11. Dixit S, Miller K, Zhu Y et al (2015b) Dual receptor-targeted theranostic nanoparticles for localized delivery and activation of photodynamic therapy drug in glioblastomas. Mol Pharm 12(9):3250–3260. CrossRefGoogle Scholar
  12. Dy GK, Adjei AA (2013) Understanding, recognizing, and managing toxicities of targeted anticancer therapies. Cancer J Clin 63(63):249–279CrossRefGoogle Scholar
  13. Felsher DW (2003) Cancer revoked: oncogenes as therapeutic targets. Nat Rev Cancer 3(5):375–380. CrossRefGoogle Scholar
  14. Goto PL, Siqueira-Moura MP, Tedesco AC (2017) Application of aluminum chloride phthalocyanine-loaded solid lipid nanoparticles for photodynamic inactivation of melanoma cells. Int J Pharm 518(1–2):228–241. CrossRefGoogle Scholar
  15. GoWf BA, Hermanto U, Rumbaughl J, Blake J, Bamberg M, Hasan T. (1994). Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br J Cancer, 70Google Scholar
  16. Gupta S, Dwarakanath BS, Chaudhury NK et al (2011) In vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects. J Cancer Res Ther 7(3):314–324. CrossRefGoogle Scholar
  17. He X, Li L, Su H, Zhou D, Song H, Wang L, Jiang X (2015). Poly(ethylene glycol)-block-poly(ε-caprolactone)–and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. Int J Nanomed 10:1791Google Scholar
  18. Hinger D, Navarro F, Kach A et al (2016) Photoinduced effects of m-tetrahydroxyphenylchlorin loaded lipid nanoemulsions on multicellular tumor spheroids. J Nanobiotechnol 14(1):68. CrossRefGoogle Scholar
  19. Jin Q, Chen Y, Wang Y et al (2014) Zwitterionic drug nanocarriers: a biomimetic strategy for drug delivery. Colloids Surf B 124:80–86. CrossRefGoogle Scholar
  20. Kakadia GP, Conway RB (2014) Solid lipid nanoparticles: a potential approach for dermal drug delivery. Am J Pharm Sci 2(5A):1–7. Google Scholar
  21. Kataokaa K, Matsumoto T, Yokoyamac M, Okanoc T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS (2000) Doxorubicin-loaded poly(ethylene glycol)-poly(b-benzyl-Laspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Release 64:143–153CrossRefGoogle Scholar
  22. Kavelin V, Fesenko O, Dubyna H et al (2017) Raman and luminescent spectra of sulfonated Zn phthalocyanine enhanced by gold nanoparticles. Nanoscale Res Lett 12(1):197. CrossRefGoogle Scholar
  23. Kim HS, Lee DY (2016) Photothermal therapy with gold nanoparticles as an anticancer medication. J Pharm Invest 47(1):19–26. CrossRefGoogle Scholar
  24. Lamch L, Bazylinska U, Kulbacka J et al (2014) Polymeric micelles for enhanced Photofrin II (R) delivery, cytotoxicity and pro-apoptotic activity in human breast and ovarian cancer cells. Photodiagn Photodyn Ther 11(4):570–585. CrossRefGoogle Scholar
  25. Lee C, Hwang HS, Lee S et al. (2017). Rabies virus-inspired silica-coated gold nanorods as a photothermal therapeutic platform for treating brain tumors. Adv Mater 29(13).
  26. Li Z, Pan LL, Zhang FL et al (2014) 5-Aminolevulinic acid-loaded fullerene nanoparticles for in vitro and in vivo photodynamic therapy. Photochem Photobiol 90(5):1144–1149. Google Scholar
  27. Ma X, Qu Q, Zhao Y (2015) Targeted delivery of 5-aminolevulinic acid by multifunctional hollow mesoporous silica nanoparticles for photodynamic skin cancer therapy. ACS Appl Mater Interfaces 7(20):10671–10676. CrossRefGoogle Scholar
  28. Madsen SJ, Gach HM, Hong SJ et al (2013) Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption. Lasers Surg Med 45(8):524–532. Google Scholar
  29. Mohammadi Z, Sazgarnia A, Rajabi O et al (2013) An in vitro study on the photosensitivity of 5-aminolevulinic acid conjugated gold nanoparticles. Photodiagn Photodyn Ther 10(4):382–388. CrossRefGoogle Scholar
  30. Navarro FP, Creusat G, Frochot C et al (2014) Preparation and characterization of mTHPC-loaded solid lipid nanoparticles for photodynamic therapy. J Photochem Photobiol B 130:161–169. CrossRefGoogle Scholar
  31. Nishiyama N, Morimoto Y, Jang W-D et al (2009) Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv Drug Deliv Rev 61(4):327–338. CrossRefGoogle Scholar
  32. O’Connor AE, Gallagher WM, Byrne AT (2009) Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 85(5):1053–1074. CrossRefGoogle Scholar
  33. Porkka K, Laakkonen P, Hoffman JA et al (2002) A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc Natl Acad Sci USA 99(11):7444–7449. CrossRefGoogle Scholar
  34. Reddy GR, Bhojani MS, McConville P et al (2006) Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res 12(22):6677–6686. CrossRefGoogle Scholar
  35. Reshetov V, Lassalle HP, Francois A et al (2013) Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo. Int J Nanomed 8:3817–3831. CrossRefGoogle Scholar
  36. Seoudi R, El-Bahy GS, El Sayed ZA (2006) Ultraviolet and visible spectroscopic studies of phthalocyanine and its complexes thin films. Opt Mater 29(2–3):304–312. CrossRefGoogle Scholar
  37. Shi J, Ma R, Wang L et al (2013) The application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatment. Int J Nanomed 8:2361–2373. CrossRefGoogle Scholar
  38. Wang D, Fei B, Halig LV, Qin X, Hu Z, Xu H, Wang YA, Chen Z, Kim S, Shin DM, Chen Z (2014). Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer. 8(7):6620–6632.
  39. Wang Y, Lin T, Zhang W et al (2015) A Prodrug-type, MMP-2-targeting nanoprobe for tumor detection and imaging. Theranostics 5(8):787–795. CrossRefGoogle Scholar
  40. Wang Y, Wang C, Ding Y et al (2016) Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy. Colloids Surf B 148:533–540. CrossRefGoogle Scholar
  41. Wu J, Lin Y, Li H et al (2017) Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy. J Colloid Interface Sci 485:251–259. CrossRefGoogle Scholar
  42. Xiong H, Guo Z, Zhang W et al (2014) Redox-responsive biodegradable PEGylated nanographene oxide for efficiently chemo-photothermal therapy: a comparative study with non-biodegradable PEGylated nanographene oxide. J Photochem Photobiol B 138:191–201. CrossRefGoogle Scholar
  43. Zabihi F, Wieczorek S, Dimde M et al (2016) Intradermal drug delivery by nanogel-peptide conjugates; specific and efficient transport of temoporfin. J Control Release 242:35–41. CrossRefGoogle Scholar
  44. Zhang LW, Al-Suwayeh SA, Hung CF et al (2011) Oil components modulate the skin delivery of 5-aminolevulinic acid and its ester prodrug from oil-in-water and water-in-oil nanoemulsions. Int J Nanomed 6:693–704. CrossRefGoogle Scholar
  45. Zhao X, Yang L, Li X et al (2015) Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug. Bioconjug Chem 26(1):128–136. CrossRefGoogle Scholar

Copyright information

© The Korean Society of Pharmaceutical Sciences and Technology 2017

Authors and Affiliations

  1. 1.College of Pharmacy, Gachon Institute of Pharmaceutical SciencesGachon UniversityIncheonSouth Korea

Personalised recommendations